Cargando…
Tramadol versus ketorolac for pain management after third molar surgery
OBJECTIVES: To compare the analgesic efficacy of preoperative intravenous (IV) ketorolac versus tramadol in preventing postoperative pain after mandibular third molar surgery. METHODOLOGY: Two hundred patients in the age group of 18–40 years with asymptomatic impacted mandibular molars were randomly...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051645/ https://www.ncbi.nlm.nih.gov/pubmed/33897187 http://dx.doi.org/10.4103/njms.NJMS_78_17 |
_version_ | 1783679772181659648 |
---|---|
author | Pathi, Jugajyoti Vidya, K. C. Sangamesh, N. C. |
author_facet | Pathi, Jugajyoti Vidya, K. C. Sangamesh, N. C. |
author_sort | Pathi, Jugajyoti |
collection | PubMed |
description | OBJECTIVES: To compare the analgesic efficacy of preoperative intravenous (IV) ketorolac versus tramadol in preventing postoperative pain after mandibular third molar surgery. METHODOLOGY: Two hundred patients in the age group of 18–40 years with asymptomatic impacted mandibular molars were randomly allocated into one of the two groups (100 in each group) and underwent third molar surgery under local anesthesia. Group I received IV ketorolac 30 mg and Group II received IV tramadol 50 mg preoperatively. The difference in postoperative pain was assessed by five primary end points: pain intensity being measured hourly by Wong-Baker pain assessment scale for 6 h, onset of analgesia, duration of action, total number of analgesics consumed, and patient's global assessment. RESULTS: Throughout the 6 h investigation period, patients reported significantly lower pain intensity scores, longer duration of action, lesser postoperative analgesic consumption, and better global assessment in ketorolac when compared to tramadol group. Patients in the ketorolac group significantly performed better than the tramadol group in terms of all parameters except onset of analgesia. All the drug-related complications were mild and did not require any investigation. CONCLUSION: The result of the present study shows that preoperative IV ketorolac 30 mg is more effective than tramadol 50 mg for postoperative pain following third molar surgery. |
format | Online Article Text |
id | pubmed-8051645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-80516452021-04-23 Tramadol versus ketorolac for pain management after third molar surgery Pathi, Jugajyoti Vidya, K. C. Sangamesh, N. C. Natl J Maxillofac Surg Original Article OBJECTIVES: To compare the analgesic efficacy of preoperative intravenous (IV) ketorolac versus tramadol in preventing postoperative pain after mandibular third molar surgery. METHODOLOGY: Two hundred patients in the age group of 18–40 years with asymptomatic impacted mandibular molars were randomly allocated into one of the two groups (100 in each group) and underwent third molar surgery under local anesthesia. Group I received IV ketorolac 30 mg and Group II received IV tramadol 50 mg preoperatively. The difference in postoperative pain was assessed by five primary end points: pain intensity being measured hourly by Wong-Baker pain assessment scale for 6 h, onset of analgesia, duration of action, total number of analgesics consumed, and patient's global assessment. RESULTS: Throughout the 6 h investigation period, patients reported significantly lower pain intensity scores, longer duration of action, lesser postoperative analgesic consumption, and better global assessment in ketorolac when compared to tramadol group. Patients in the ketorolac group significantly performed better than the tramadol group in terms of all parameters except onset of analgesia. All the drug-related complications were mild and did not require any investigation. CONCLUSION: The result of the present study shows that preoperative IV ketorolac 30 mg is more effective than tramadol 50 mg for postoperative pain following third molar surgery. Wolters Kluwer - Medknow 2020 2020-12-16 /pmc/articles/PMC8051645/ /pubmed/33897187 http://dx.doi.org/10.4103/njms.NJMS_78_17 Text en Copyright: © 2020 National Journal of Maxillofacial Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Pathi, Jugajyoti Vidya, K. C. Sangamesh, N. C. Tramadol versus ketorolac for pain management after third molar surgery |
title | Tramadol versus ketorolac for pain management after third molar surgery |
title_full | Tramadol versus ketorolac for pain management after third molar surgery |
title_fullStr | Tramadol versus ketorolac for pain management after third molar surgery |
title_full_unstemmed | Tramadol versus ketorolac for pain management after third molar surgery |
title_short | Tramadol versus ketorolac for pain management after third molar surgery |
title_sort | tramadol versus ketorolac for pain management after third molar surgery |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051645/ https://www.ncbi.nlm.nih.gov/pubmed/33897187 http://dx.doi.org/10.4103/njms.NJMS_78_17 |
work_keys_str_mv | AT pathijugajyoti tramadolversusketorolacforpainmanagementafterthirdmolarsurgery AT vidyakc tramadolversusketorolacforpainmanagementafterthirdmolarsurgery AT sangameshnc tramadolversusketorolacforpainmanagementafterthirdmolarsurgery |